Acadian Asset Management
NEOS

Acadian Asset Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Acadian Asset Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,918
Closed -$8K – 2418
2020
Q3 		$8K Buy
+15,918
New +$10.8K ﹤0.01% 2125
2019
Q3 		– Sell
-30,645
Closed -$40K – 2079
2019
Q2 		$40K Buy
+30,645
New +$56.4K ﹤0.01% 1519

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acadian Asset Management's NEOS Position: Q4 2020 in Review

Acadian Asset Management sold out of Neos Therapeutics, Inc (NEOS) in Q4 2020, closing a stake of 15,918 shares — an estimated $8K sold.

Acadian Asset Management first reported a position in NEOS in Q2 2019 and held it in 2 quarters. The position peaked at $40K in Q2 2019. 37 funds tracked by Wall St. Rank hold NEOS as of Q4 2020.

  • Acadian Asset Management reported no remaining Neos Therapeutics, Inc position as of Q4 2020 after selling out during the quarter.
  • Acadian Asset Management sold 15,918 Neos Therapeutics, Inc shares in Q4 2020, an estimated $8K.
  • Acadian Asset Management first reported a position in Neos Therapeutics, Inc in Q2 2019 and held it in 2 quarters.
  • Acadian Asset Management's Neos Therapeutics, Inc position peaked at $40K in Q2 2019.
  • 37 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2020.

Based on Acadian Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.